Repligen Corporation - Common Stock (RGEN)

Repligen Corporation is a bioprocessing company that specializes in developing and manufacturing products that support the process of biologics, specifically in the production of therapeutics such as monoclonal antibodies and gene therapies

The company offers a range of innovative solutions, including critical components, systems, and services that enhance efficiency and reliability in biomanufacturing. By focusing on advanced technologies and customizable solutions, Repligen aims to improve the workflow of biopharmaceutical production, making it more cost-effective and scalable for its clients in the life sciences industry.